Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer

Authors

  • Maja Lynge Rasmussen Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Gabor Liposits Department of Oncology, Herning Hospital, Denmark
  • Subethini Yogendram Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Anders Bonde Jensen Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Søren Linnet Department of Oncology, Herning Hospital, Denmark
  • Sven Tyge Langkjer Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

DOI:

https://doi.org/10.3109/0284186X.2014.918277

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2014-09-01

How to Cite

Lynge Rasmussen, M., Liposits, G., Yogendram, S., Bonde Jensen, A., Linnet, S., & Tyge Langkjer, S. (2014). Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer. Acta Oncologica, 53(9), 1275–1277. https://doi.org/10.3109/0284186X.2014.918277

Issue

Vol. 53 No. 9 (2014): Acta Oncologica

Section

Articles